Zhu Jingyi | Cataract | Excellence in Research Award

Published on by Book of Award

Dr. Zhu Jingyi | Cataract | Excellence in Research Award

The General Hospital of Central Theater Command | China

Dr. Zhu Jingyi is an emerging researcher in vision science and ophthalmic biology, with a focused research profile encompassing retinal pathophysiology, neuroprotection, and molecular mechanisms of ocular diseases. The scholarly output comprises 8 research documents, which have received 89 citations from 87 citing publications, yielding an h-index of 6, reflecting growing academic impact. The research explores cellular and metabolic responses in glaucoma, retinal ischemia–reperfusion injury, and optic nerve damage, with particular emphasis on water transport regulation, ferroptosis, oxidative stress, and energy metabolism in retinal cells. Significant contributions include studies on AQP1-mediated lens physiology, DJ-1–saRNA–based nucleic acid delivery systems for retinal protection, and signaling pathways such as Rap1, YAP/TAZ, and Warburg-like glycolysis in retinal ganglion cell survival. This body of work advances mechanistic understanding and therapeutic strategies for degenerative and ischemic eye diseases.

Citation Metrics (Scopus)

100
80
60
40
0

Citations
89

Documents
8

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Marcel Brown | Medicine and Dentistry | Research Excellence Award

Published on by Book of Award

Dr. Marcel Brown | Medicine and Dentistry | Research Excellence Award

Atrium Health Wake Forest Baptist | United States

Dr. Marcel Brown is a clinician–scientist whose research portfolio integrates orthopaedic surgery, regenerative medicine, translational molecular science, and cardiovascular physiology, with a strong emphasis on clinically impactful, mechanism-driven investigation. His scholarly output comprises 7 peer-reviewed documents, which have collectively received 145 citations, reflecting an h-index of 3, indicative of consistent citation impact across his publications. His research experience spans advanced orthopaedic outcomes research, musculoskeletal infection prevention, stem cell and acellular biologic therapies for osteoarthritis and post-traumatic osteoarthritis, and translational studies evaluating tissue regeneration, inflammation, and functional recovery using in vitro, in vivo, and ex vivo models. Complementing this work, he has contributed substantially to cardiovascular and exercise physiology research, including investigations into exercise-induced cardiac remodeling, pulmonary vascular disease, metabolic and hormonal responses to physical stress, and molecular mechanisms underlying maladaptive vascular fibrosis. His interdisciplinary collaborations have resulted in publications across high-impact journals in orthopaedics, translational medicine, cardiovascular science, and cell biology, including original research articles, systematic analyses, and clinically relevant case reports. Collectively, his research demonstrates a sustained commitment to bridging basic science with clinical application, advancing evidence-based surgical practice, regenerative strategies, and cardiometabolic health through rigorously designed translational and outcomes-focused studies.

 

Citation Metrics (Scopus)

150120

90

60

30

0

Citations
145

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Risk factors for failure after lumbar tubular microdecompression without stabilization
– Journal of the American Academy of Orthopaedic Surgeons, 2025

MInjie Wang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Prof. Minjie Wang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Inner Mongolia Medical University | China

Prof. Minjie Wang is an accomplished biomedical researcher with a strong scholarly record, reflected by an h-index of 6, 15 peer-reviewed documents, and 93 citations. His research focuses on the discovery and functional characterization of active substances from Traditional Chinese Medicine and Mongolian Medicine, with particular emphasis on the pathological mechanisms of cardiovascular and cerebrovascular diseases and the identification of therapeutic drug targets. A major theme of his work is the role of AMP-activated protein kinase (AMPK) in vascular inflammation, endothelial dysfunction, atherosclerosis, metabolic syndrome, and adipose tissue remodeling. His studies integrate advanced in vivo animal models—including atherosclerosis, myocardial ischemia-reperfusion injury, arrhythmia, and cerebral ischemia—with comprehensive in vitro approaches encompassing cell culture, molecular biology, immunohistochemistry, and biochemical analysis. Prof. Wang has published extensively in high-impact journals such as European Heart Journal, Cell Death & Disease, Frontiers in Microbiology, Acta Pharmacologica Sinica, and European Journal of Pharmacology, contributing significant insights into vascular biology, inflammation, metabolism, and translational pharmacology. His work also includes patented innovations related to AMPK activators for vascular inflammation and endothelial protection, underscoring both scientific depth and translational relevance.

 

Citation Metrics (Scopus)

10080

60

40

20

0

Citations
93

Documents
15

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

 

Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Prof. Lingmin Zhang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Guangzhou Medical University | China

Prof. Lingmin Zhang is a leading researcher whose work integrates pharmaceutics, biomedical materials, and gene delivery, contributing significantly to advanced therapeutic strategies, particularly in lung cancer and inflammatory diseases. With 3,077 citations , 79 publications, and an h-index of 27, the researcher's scholarly impact is widely recognized. The work focuses on innovative nano-based and biomimetic delivery platforms, including nano-PROTACs, exosomes, microfluidic nanovesicles, and CRISPR/Cas9 carriers, offering transformative possibilities for targeted and precision medicine. Supported by major grants from the National Natural Science Foundation of China (projects 82572415, 82072047, 81700382), the researcher has developed cutting-edge strategies such as reprogramming tumor-associated macrophages, overcoming drug resistance in lung cancer, and reversing epigenetic silencing through nanoparticle-mediated gene delivery. Influential publications in high-impact journals—including Journal of Controlled Release, Drug Resistance Updates, ACS Nano, Angewandte Chemie, Advanced Science, and Molecular Cancer—highlight breakthroughs in nano-therapeutics, PROTAC technologies, artificial exosomes, and nucleic-acid delivery systems. Collectively, these contributions position the researcher at the forefront of translational nanomedicine, with ongoing work offering new directions for precision oncology, regenerative strategies, and next-generation drug delivery platforms.

Profile : Scopus | Orcid

Featured Publication

He, M., Peng, Q., Yang, Q., Guan, X., Liu, Q., Chen, R., Zhou, D., Wang, L., Zhang, Y., Li, S., Su, J., & Zhang, L. (2026). In situ reprogramming of tumor associated macrophages with versatile nano-epigenetic inhibitor for lung cancer therapy. Journal of Controlled Release, 2026, 114497.

Zhang, L., He, L., Lin, Y., Wei, J., Tang, S., Lei, X., Lin, X., Zhou, D., Fu, L., Li, Y., He, J., Liang, L., & Yu, X. (2026). The novel strategy to overcome drug-resistant lung cancer: Dual targeting delivery of PROTAC to inhibit cancer-associated fibroblasts and lung cancer cells. Drug Resistance Updates, 84, 101316.

Chen, S., Chen, E., Su, J., Gong, Y., Tang, S., Qin, A., Shen, A., Tang, S., & Zhang, L. (2025). Magnetically navigated nano-PROTAC ameliorates acute lung injury. Journal of Nanobiotechnology, 23, 622.

Li, X., Qin, Z., Wang, S., Zhang, L., & Jiang, X. (2025). Microfluidics-assembled nanovesicles for nucleic acid delivery. Accounts of Chemical Research, 58, 570–582.

Liang, L., Peng, W., Qin, A., Zhang, J., Chen, R., Zhou, D., Zhang, X., Zhou, N., Yu, X., & Zhang, L. (2024). Intracellularly synthesized artificial exosome treats acute lung injury. ACS Nano, 18(32), 21009–21023.

Guan, X., Xu, X., Tao, Y., Deng, X., He, L., Lin, Z., Chang, J., Huang, J., Zhou, D., Yu, X., Wei, M., & Zhang, L. (2024). Dual targeting and bioresponsive nano-PROTAC induced precise and effective lung cancer therapy. Journal of Nanobiotechnology, 22, 692.

Zhang, L., Lin, Y., Li, S., Guan, X., & Jiang, X. (2023). In situ reprogramming of tumor-associated macrophages with internally and externally engineered exosomes. Angewandte Chemie International Edition, 62(11), e202217089.

Liang, L., Cen, H., Huang, J., Qin, A., Xu, W., Wang, S., Chen, Z., Tan, L., Zhang, Q., Yu, X., Yang, X., & Zhang, L. (2022). The reversion of DNA methylation-induced miRNA silence via biomimetic nanoparticles-mediated gene delivery for efficient lung adenocarcinoma therapy. Molecular Cancer, 21(1), 186.

Zhang, H., Peng, R., Chen, S., Shen, A., Zhao, L., Tang, W., Wang, X., Li, Z., Zha, Z., Yi, M., & Zhang, L. (2022). Versatile nano-PROTAC-induced epigenetic reader degradation for efficient lung cancer therapy. Advanced Science, 9(29), 2202039.

Zhang, L., Wang, L., Xie, Y., Wang, P., Deng, S., Qin, A., Zhang, J., Yu, X., Zheng, W., & Jiang, X. (2019). Triple-targeting delivery of CRISPR/Cas9 to reduce the risk of cardiovascular diseases. Angewandte Chemie International Edition, 58(36), 12404–12408.

Judith Röske | Biochemistry, Genetics and Molecular Biology | Women Research Award

Published on by Book of Award

Mrs. Judith Röske | Biochemistry, Genetics and Molecular Biology | Women Research Award

University of Luebeck | Germany

Mrs. Judith Röske is a dedicated researcher with a strong focus on molecular virology, antiviral drug discovery, and protease-targeted therapeutic development, contributing to 13 scientific publications across high-impact journals. Her work explores the binding behavior of small-molecule inhibitors to viral 3C proteases, including SARS-CoV-2, EV-D68, EV-A71, and HAV, as well as host proteases such as cathepsins and calpain-1. With expertise in photometry, nanoDSF, MST, and SPR, she has optimized methods for determining key biochemical parameters such as IC₅₀, Tm, and Kᴅ, enabling the effective screening of lead compounds for broad-spectrum antivirals. Her research further investigates RNA-binding mechanisms in HAV 3C protease, shedding light on dual-targeting strategies that may advance anti-picornaviral drug development. She has contributed to influential studies on SARS-CoV-2 main protease inhibitors, including work on novel warhead chemistries, α-ketoamide derivatives, and diastereomeric optimization, reinforcing her impact in antiviral medicinal chemistry. Additionally, earlier contributions in transplant biology and liver preservation highlight her versatility in biochemical and molecular research. Through rigorous structural, kinetic, and biophysical analyses, her body of work adds valuable insight into protease inhibition and therapeutic innovation, supported by a growing citation record within the scientific community.

Profiles : Scopus | Orcid

Featured Publications

Theodoropoulou, M. A., El Kilani, H., Mantzourani, C., Jochmans, D., Neyts, J., Zhang, K., Röske, J., Kokotou, M. G., Hilgenfeld, R., & Kokotos, G. (2025). Thiazolyl 4-carboxylate ketone as a new warhead for a highly potent SARS-CoV-2 main protease inhibitor. European Journal of Medicinal Chemistry, 25(11), 118436.

Akula, R. K., El Kilani, H., Metzen, A., Röske, J., Zhang, K., Göhl, M., Arisetti, N., Marsh, G. P., Maple, H. J., Cooper, M. S., et al. (2025). Structure-based optimization of pyridone α-ketoamides as inhibitors of the SARS-CoV-2 main protease. Journal of Medicinal Chemistry, 68(1).

Cooper, M. S., Zhang, L., Ibrahim, M., Zhang, K., Sun, X., Röske, J., Göhl, M., Brönstrup, M., Cowell, J. K., Sauerhering, L., et al. (2022). Diastereomeric resolution yields highly potent inhibitor of SARS-CoV-2 main protease. Journal of Medicinal Chemistry.

Bernard, V., Gebauer, N., Dinh, T., Stegemann, J., Feller, A. C., & Merz, H. (2014). Applicability of next-generation sequencing to decalcified formalin-fixed and paraffin-embedded chronic myelomonocytic leukaemia samples. International Journal of Clinical and Experimental Pathology.

Le Minh, K., Berger, A., Eipel, C., Kuhla, A., Minor, T., Stegemann, J., & Vollmar, B. (2011). Uncoupling protein-2 deficient mice are not protected against warm ischemia/reperfusion injury of the liver. Journal of Surgical Research, 167.

Stegemann, J., Hirner, A., Rauen, U., & Minor, T. (2010). Use of a new modified HTK solution for machine preservation of marginal liver grafts. Journal of Surgical Research.

Koetting, M., Stegemann, J., & Minor, T. (2010). Dopamine as additive to cold preservation solution improves postischemic integrity of the liver. Transplant International, 23.

Minor, T., Stegemann, J., Hirner, A., & Koetting, M. (2009). Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning. Liver Transplantation.

Stegemann, J., & Minor, T. (2009). Energy charge restoration, mitochondrial protection and reversal of preservation-induced liver injury by hypothermic oxygenation prior to reperfusion. Cryobiology.

Stegemann, J., Hirner, A., Rauen, U., & Minor, T. (2009). Gaseous oxygen persufflation or oxygenated machine perfusion with Custodiol-N for long-term preservation of ischemic rat livers? Cryobiology.

Le Minh, K., Kuhla, A., Abshagen, K., Minor, T., Stegemann, J., Ibrahim, S., Eipel, C., & Vollmar, B. (2009). Uncoupling protein-2 deficiency provides protection in a murine model of endotoxemic acute liver failure. Critical Care Medicine.

Manekeller, S., Seinsche, A., Stegemann, J., & Hirner, A. (2008). Optimising post-conditioning time of marginal donor livers. Langenbeck's Archives of Surgery.

Manekeller, S., Schuppius, A., Stegemann, J., Hirner, A., & Minor, T. (2007). Role of perfusion medium, oxygen and rheology for endoplasmic reticulum stress-induced cell death after hypothermic machine preservation of the liver. Transplant International.

Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

Published on by Book of Award

Mrs. Sophie Grigolo | Immunology and Microbiology | Young Researcher Award

University of Fribourg | Switzerland

Mrs. Sophie Grigolo is an emerging researcher specializing in cellular and molecular biology, with a strong focus on cancer research, particularly clear-cell renal-cell carcinoma (ccRCC). Her work encompasses extensive laboratory expertise in cell culture using human kidney cancer cell lines (A-498, ACHN, Caki-1, and Caki-2) and a range of analytical assays including BrdU Cell Proliferation, MTT, LDH, and Live-or-Dye™ Fixable Viability Staining. She is proficient in advanced molecular biology techniques such as polymerase chain reaction (PCR), agarose gel electrophoresis, western blotting, genotyping, flow cytometry, and immunohistochemistry (IHC), which she applies to elucidate cancer cell behavior and therapeutic responses. Her publications, including studies on immunotherapy in ccRCC and the role of IL-2 receptor expression in renal carcinoma cells, contribute to advancing understanding of tumor immunology and targeted therapies. Sophie has also shared her findings at prestigious scientific forums, including the International Student Congress of (bio)Medical Sciences and the Annual European Student Symposium on Anatomical Research, where her work has earned recognition for excellence. Through her research and technical acumen, she continues to contribute to the evolving field of cancer biology and the development of innovative therapeutic approaches.

Profile : Orcid

Featured Publications

Grigolo, S., Fellay, I., & Filgueira, L. (2025). IL-2 receptor expression in renal cell carcinoma cells: IL-2 influences cell survival and induces cell death. Current Issues in Molecular Biology, 47(10), 830.

Grigolo, S., & Filgueira, L. (2024). Immunotherapy of clear-cell renal-cell carcinoma. Cancers, 16, 2092.

Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Mrs. Valentina Mihaylova | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Medical University-Plovdiv | Bulgaria

Mrs. Valentina Mihaylova is a dedicated researcher and specialist in medical chemistry with a strong focus on cellular metabolism, mitochondrial function, oxidative stress, and autoimmune diseases. With an h-index of 2, she has authored five scientific publications, which have collectively garnered 14 citations, reflecting her growing impact in medical biology and clinical research. Her work encompasses the study of markers of oxidative stress and insulin resistance in chronic autoimmune Hashimoto’s thyroiditis, cellular metabolic profiling in children with autism spectrum disorders, and the evaluation of therapeutic effects in rheumatoid arthritis through mitochondrial function and bioenergetic metabolism. Mrs. Mihaylova’s research also explores intestinal permeability, systemic inflammation, and the pharmacological effects of treatments such as methotrexate and JAK inhibitors on mitochondrial function and oxidative stress. She has actively contributed to numerous national and international conferences, presenting pioneering findings on the role of mitochondria, autophagy, and inflammation in autoimmune and rheumatologic conditions. Her academic and professional trajectory, spanning positions from clinical chemist to Master of Medical Chemistry at the Medical University of Plovdiv, is marked by a commitment to advancing knowledge in medical biology and translational research. Through her multidisciplinary approach, Mrs. Mihaylova continues to elucidate complex biochemical mechanisms underlying disease pathology and therapeutic responses, establishing herself as an emerging contributor to the field of medical and clinical biochemistry.

Profiles : Scopus | Orcid

Featured Publications

Mihaylova, V., Tomov, D., Karalilova, R., Batalov, Z., Batalov, A., Sarafian, V., & Kazakova, M. (2025). Effects of methotrexate and tofacitinib on mitochondrial function and oxidative stress in human synovial cells in vitro. International Journal of Molecular Sciences, 26(17), 8173.

Tomov, D. G., Levterova, B. A., Mihaylova, V. N., Troev, D. M., Miteva, M. Z., Uzunova, Y. I., & Orbetzova, M. M. (2024). Influence of the increase in intestinal permeability and microbiota change in the development of Hashimoto's thyroiditis: A systematic review. Endocrine and Metabolic Science, 100195.

Mihaylova, V., Kazakova, M., Batalov, Z., Karalilova, R., Batalov, A., & Sarafian, V. (2023). JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: A pilot study. Rheumatology International.

Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Assist. Prof. Dr. Panpan Hou | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Macau University Of Science And Technology | Macau

Assist. Prof. Dr. Panpan Hou is a distinguished researcher in the field of Biomedical Engineering and Biophysics, with a prolific record of 375 documents, 541 citations, and an h-index of 16. After obtaining a B.S. in Biomedical Engineering and a Ph.D. in Biophysics from Huazhong University of Science and Technology, Dr. Hou completed postdoctoral training at Washington University in St. Louis before joining Macau University of Science and Technology as an Assistant Professor in 2021. Dr. Hou’s research focuses on ion channel physiology, voltage-sensor domain (VSD) mechanisms, and electro-mechanical coupling, elucidating complex molecular processes such as the VSD-pore coupling in KCNQ1 channels and identifying novel modulators with therapeutic potential. He has made significant contributions to drug screening, cardiovascular disease modeling, and electrophysiology, publishing high-impact work in journals including Nature Communications, PNAS, eLife, Circulation Research, and Scientific Reports. Dr. Hou has received multiple awards including the AHA Postdoctoral Fellowship, Best Poster Awards at international symposia, and the 2025 Best Research Output Award from Macau University of Science and Technology. Beyond research, he actively mentors students, serves on editorial boards, and contributes to national and international scientific societies. With a strong track record of innovation, mentorship, and high-impact publications, Dr. Hou exemplifies excellence in biomedical research and is poised to advance the understanding of ion channel physiology and therapeutic interventions.

Profiles : Scopus | Orcid | Google Scholar

Featured Publications

Zhong, L., Lin, X., Cheng, X., Wan, S., Hua, Y., Nan, W., Hu, B., Peng, X., Zhou, Z., Zhang, Q., Yang, H., Noé, F., Yan, Z., Jiang, D., Zhang, H., Liu, F., Xiao, C., Zhou, Z., Mou, Y., Yu, H., Ma, L., Huang, C., Wong, V. K. W., Chung, S. K., Shen, B., Jiang, Z.-H., Neher, E., Zhu, W., Zhang, J., & Hou, P. (2025). Secondary structure transitions and dual PIP2 binding define cardiac KCNQ1-KCNE1 channel gating. Cell Research.

Hou, P., Zhao, L., Zhong, L., Shi, J., Wang, H. Z., Gao, J., Liu, H., Zuckerman, J., Cohen, I. S., & Cui, J. (2024). The fully activated open state of KCNQ1 controls the cardiac “fight-or-flight” response. PNAS Nexus.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2022). Author correction: A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Dou, A., Kang, P. W., Hou, P., Zaydman, M. A., Zheng, J., Jegla, T., & Cui, J. (2021). Principles of sensor-effector organization in six-transmembrane ion channels.

Lin, Y., Grinter, S. Z., Lu, Z., Xu, X., Wang, H. Z., Liang, H., Hou, P., Gao, J., Clausen, C., & Shi, J. (2021). Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects. Proceedings of the National Academy of Sciences.

Liu, Y., Xu, X., Gao, J., Naffaa, M. M., Liang, H., Shi, J., Wang, H. Z., Yang, N.-D., Hou, P., & Zhao, W. (2020). A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation. Communications Biology.

Taylor, K. C., Kang, P. W., Hou, P., Yang, N.-D., Kuenze, G., Smith, J. A., Shi, J., Huang, H., McFarland White, K., & Peng, D. (2020). Structure and physiological function of the human KCNQ1 channel voltage sensor intermediate state. eLife.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2020). Two-stage electro–mechanical coupling of a KV channel in voltage-dependent activation. Nature Communications.

Zhu, W., Mazzanti, A., Voelker, T. L., Hou, P., Moreno, J. D., Angsutararux, P., Naegle, K. M., Priori, S. G., & Silva, J. R. (2019). Predicting patient response to the antiarrhythmic mexiletine based on genetic variation: Personalized medicine for long QT syndrome. Circulation Research.

Hou, P., Kang, P. W., Kongmeneck, A. D., Yang, N.-D., Liu, Y., Shi, J., Xu, X., McFarland White, K., Zaydman, M. A., Kasimova, M. A., Seebohm, M., Zhong, L., Zou, X., Tarek, M., & Cui, J. (2019). Two-stage electro-mechanical coupling of a KV channel in voltage-dependent activation.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling. eLife.

Hou, P., Shi, J., McFarland White, K., Gao, Y., & Cui, J. (2019). ML277 specifically enhances pore opening of KCNQ1 with VSD at the activated state by modulating VSD-pore coupling.

Hou, P., Eldstrom, J., Shi, J., Zhong, L., McFarland, K., Gao, Y., Fedida, D., & Cui, J. (2017). Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening. Nature Communications.

Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Monash University | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Masroor Badshah’s academic foundation is marked by a rigorous pursuit of medicine and anatomical sciences. Beginning with his degree in Medicine and Surgery, he developed an early research interest in the clinical relevance of anatomy, completing projects on skin diseases and vascular variations. His postgraduate studies at the University of Dundee expanded his expertise into human anatomy, where he defended a dissertation on carotid artery variations. This path led him to Monash University, where he earned his doctorate in medicine, focusing on oxytocin signaling in regulating the myogenic tone of the prostate and bladder. These early endeavors established a solid base for his later contributions to pharmacology and biomedical sciences.

Professional Endeavors

Dr. Badshah’s professional journey spans multiple countries, reflecting both versatility and international recognition. He began his teaching career as a lecturer and assistant professor in human anatomy at medical institutions in Pakistan before moving to Scotland and later Australia. His teaching associate roles at Monash University and research assistantship at the Monash Institute of Pharmaceutical Sciences allowed him to mentor students, design innovative teaching methodologies, and participate in collaborative research. His clinical internships in medicine and surgery also provided him with practical exposure that enriched his academic and research perspectives.

Contributions and Research Focus

At the core of Dr. Badshah’s career lies his dedication to advancing knowledge in pharmacology, toxicology, and pharmaceutical sciences. His doctoral work investigated the pharmacological role of oxytocin receptor antagonists in bladder and prostate function, with implications for overactive bladder treatments. His broader research includes studies in human surface anatomy, craniofacial asymmetry, morphometry of skeletal structures, and the clinical relevance of anatomical variations. By combining anatomical precision with pharmacological inquiry, he bridges the gap between foundational science and therapeutic application.

Accolades and Recognition

Throughout his career, Dr. Badshah has been honored with prestigious awards and scholarships, including the Monash Graduate Scholarship, Faculty International Tuition Scholarship, and the University of Dundee Tuition Scholarship. His academic excellence is reflected in multiple publications in peer-reviewed journals such as Biomedicines, Clinical Anatomy, and the Italian Journal of Anatomy and Embryology. He has also been a frequent presenter at international conferences, where his research findings on oxytocin signaling and anatomical morphometry have received recognition from the scientific community.

Impact and Influence

Dr. Badshah’s influence extends beyond research publications to shaping the next generation of medical and pharmaceutical scientists. His teaching philosophy emphasizes critical thinking, active participation, and evidence-based learning. By integrating innovative methodologies and fostering a collaborative learning environment, he has left a lasting impression on his students across different institutions. His work in surface anatomy and pharmacological sciences contributes to both clinical education and translational research, making his influence both academic and practical.

Legacy and Future Contributions

As a researcher with interdisciplinary expertise, Dr. Badshah’s legacy lies in his ability to merge anatomy with pharmacology for improved clinical outcomes. His ongoing research into bladder and prostate physiology offers potential breakthroughs in addressing urological disorders. Looking ahead, he aims to expand his collaborations globally, secure independent research leadership, and explore translational aspects of his work that could lead to therapeutic innovations. His legacy will continue to inspire young researchers and contribute to the evolution of biomedical sciences.

Publication

Investigating the Pharmacological Impact of Atosiban, an Oxytocin Receptor Antagonist, on Bladder and Prostate Contractions Within Obese and Non-Obese Rats
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Sarah M. Turpin-Nolan, Khaled A. Elnahriry, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2025

Age-Dependent Effects of Oxytocin and Oxytocin Receptor Antagonists on Bladder Contractions: Implications for the Treatment of Overactive Bladder Syndrome
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2024

The Effects of Age on Prostatic Responses to Oxytocin and the Effects of Antagonists
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2023

Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan
Authors: Sana Hussain, Jamshed Hasnain, Zareen Hussain, Masroor Badshah, Hafeez Siddique, Christina Fiske, April Pettit
Journal: The Open Infectious Diseases Journal
Year: 2018

Morphology of the Human Hard Palate: A Study on Dry Skulls
Authors: Masroor Badshah, Roger Soames, Muhammad Jaffar Khan, Jamshaid Hasnain
Journal: Italian Journal of Anatomy and Embryology
Year: 2018

Conclusion

Dr. Masroor Badshah exemplifies the qualities of a dedicated academic, skilled researcher, and inspiring mentor. His career trajectory reflects a balance of teaching, research, and clinical exposure, with a focus on advancing pharmacology and anatomical sciences. His publications, conference presentations, and mentoring of students have strengthened his academic influence, while his research contributions offer practical applications in medicine. With a strong foundation and a vision for global collaboration, Dr. Badshah’s journey positions him as a leading figure in biomedical and pharmaceutical research, making his recognition as a distinguished researcher both timely and well-deserved.